Compugen to present ovarian cancer trial data at ESMO congress

Go back to Compugen to present ovarian cancer trial data at ESMO congress
Compugen Ltd (NASDAQ: CGEN) Delayed: 2.07 --0 (-0%)
Previous Close $2.07    52 Week High $7.79 
Open $2.07    52 Week Low $4.32 
Day High $2.07    P/E N/A 
Day Low $2.07    EPS $-0.36 
Volume